Enobosarm

DB12078InvestigationalSmall molecule

Enobosarm has been used in trials studying the treatment of Stress Urinary Incontinence and Triple Negative Breast Cancer.

Chemical structure of Enobosarm
Mechanism
Curator reviewed
Formula / weight
C19H14F3N3O3 · 389.328 g/mol (avg)
Also known as
Ostarine
Code names
GTX-024 · MK-2866

Resolves to

Compound
UNIIO3571H3R8NCAS841205-47-8ChEMBLCHEMBL1738889PubChem11326715KEGGD10221
Clinical / RWD
RxNorm2168587
Structure
InChIKeyJNGVJMBLXIUVRD-SFHVURJKSA-NSMILESC[C@](O)(COC1=CC=C(C=C1)C#N)C(=O)NC1=CC=C(C#N)C(=C1)C(F)(F)F
Targets
P10275AR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
14Clinical trialsPhase, status and sponsor resolved per trial
Sign in
3+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Enobosarm, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In